Literature DB >> 19949299

Over the barrier and through the blood: to CNS delivery we go.

Kevin D Foust, Brian K Kaspar.   

Abstract

Entities:  

Mesh：

Year:  2009        PMID： 19949299      PMCID： PMC2911437          DOI： 10.4161/cc.8.24.10245

Source DB:  PubMed          Journal:  Cell Cycle        ISSN： 1551-4005            Impact factor:   4.534


× No keyword cloud information.
  12 in total

Review 1.  Dynamics of CNS barriers: evolution, differentiation, and modulation.

Authors:  N Joan Abbott
Journal:  Cell Mol Neurobiol       Date:  2005-02       Impact factor: 5.046

Review 2.  Glial cells as intrinsic components of non-cell-autonomous neurodegenerative disease.

Authors:  Christian S Lobsiger; Don W Cleveland
Journal:  Nat Neurosci       Date:  2007-11       Impact factor: 24.884

3.  AAV9: a potential blood-brain barrier buster.

Authors:  Fredric P Manfredsson; Aaron C Rising; Ronald J Mandel
Journal:  Mol Ther       Date:  2009-03       Impact factor: 11.454

4.  The neonatal blood-brain barrier is functionally effective, and immaturity does not explain differential targeting of AAV9.

Authors:  Norman R Saunders; C Joakim Ek; Katarzyna M Dziegielewska
Journal:  Nat Biotechnol       Date:  2009-09       Impact factor: 54.908

5.  Development of the blood vessels and extracellular spaces during postnatal maturation of rat cerebral cortex.

Authors:  D W Caley; D S Maxwell
Journal:  J Comp Neurol       Date:  1970-01       Impact factor: 3.215

6.  Intravascular AAV9 preferentially targets neonatal neurons and adult astrocytes.

Authors:  Kevin D Foust; Emily Nurre; Chrystal L Montgomery; Anna Hernandez; Curtis M Chan; Brian K Kaspar
Journal:  Nat Biotechnol       Date:  2008-12-21       Impact factor: 54.908

7.  Crossing the rubicon.

Authors:  Pedro R Lowenstein
Journal:  Nat Biotechnol       Date:  2009-01       Impact factor: 54.908

8.  A Nurr1/CoREST pathway in microglia and astrocytes protects dopaminergic neurons from inflammation-induced death.

Authors:  Kaoru Saijo; Beate Winner; Christian T Carson; Jana G Collier; Leah Boyer; Michael G Rosenfeld; Fred H Gage; Christopher K Glass
Journal:  Cell       Date:  2009-04-03       Impact factor: 41.582

Review 9.  Human brain mapping: hemodynamic response and electrophysiology.

Authors:  Hiroshi Shibasaki
Journal:  Clin Neurophysiol       Date:  2008-01-09       Impact factor: 3.708

10.  Retrograde viral delivery of IGF-1 prolongs survival in a mouse ALS model.

Authors:  Brian K Kaspar; Jerònia Lladó; Nushin Sherkat; Jeffrey D Rothstein; Fred H Gage
Journal:  Science       Date:  2003-08-08       Impact factor: 47.728
View more
  9 in total

Review 1.  Viral vectors for gene delivery to the central nervous system.

Authors:  Thomas B Lentz; Steven J Gray; R Jude Samulski
Journal:  Neurobiol Dis       Date:  2011-10-07       Impact factor: 5.996

2.  Adeno-associated virus serotype 9 transduction in the central nervous system of nonhuman primates.

Authors:  Lluis Samaranch; Ernesto A Salegio; Waldy San Sebastian; Adrian P Kells; Kevin D Foust; John R Bringas; Clementine Lamarre; John Forsayeth; Brian K Kaspar; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2012-03-28       Impact factor: 5.695

3.  Strong cortical and spinal cord transduction after AAV7 and AAV9 delivery into the cerebrospinal fluid of nonhuman primates.

Authors:  Lluis Samaranch; Ernesto A Salegio; Waldy San Sebastian; Adrian P Kells; John R Bringas; John Forsayeth; Krystof S Bankiewicz
Journal:  Hum Gene Ther       Date:  2013-05-02       Impact factor: 5.695

4.  Delivery of therapeutic agents through intracerebroventricular (ICV) and intravenous (IV) injection in mice.

Authors:  Jacqueline J Glascock; Erkan Y Osman; Tristan H Coady; Ferrill F Rose; Monir Shababi; Christian L Lorson
Journal:  J Vis Exp       Date:  2011-10-03       Impact factor: 1.355

5.  Evaluation of Readministration of a Recombinant Adeno-Associated Virus Vector Expressing Acid Alpha-Glucosidase in Pompe Disease: Preclinical to Clinical Planning.

Authors:  Manuela Corti; Brian Cleaver; Nathalie Clément; Thomas J Conlon; Kaitlyn J Faris; Gensheng Wang; Janet Benson; Alice F Tarantal; Davis Fuller; Roland W Herzog; Barry J Byrne
Journal:  Hum Gene Ther Clin Dev       Date:  2015-09       Impact factor: 5.032

6.  Adeno-Associated Viral Vector Delivery to the Enteric Nervous System: A Review.

Authors:  Sara E Gombash
Journal:  Postdoc J       Date:  2015-08

Review 7.  Clinical and molecular features and therapeutic perspectives of spinal muscular atrophy with respiratory distress type 1.

Authors:  Fiammetta Vanoli; Paola Rinchetti; Francesca Porro; Valeria Parente; Stefania Corti
Journal:  J Cell Mol Med       Date:  2015-06-20       Impact factor: 5.310

8.  Systemic AAV9 gene therapy using the synapsin I promoter rescues a mouse model of neuronopathic Gaucher disease but with limited cross-correction potential to astrocytes.

Authors:  Giulia Massaro; Michael P Hughes; Sammie M Whaler; Kerri-Lee Wallom; David A Priestman; Frances M Platt; Simon N Waddington; Ahad A Rahim
Journal:  Hum Mol Genet       Date:  2020-07-29       Impact factor: 6.150

Review 9.  In vivo methods for acute modulation of gene expression in the central nervous system.

Authors:  Andrzej W Cwetsch; Bruno Pinto; Annalisa Savardi; Laura Cancedda
Journal:  Prog Neurobiol       Date:  2018-04-22       Impact factor: 11.685
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.